Endocannabinoid System vs. Neurotransmitters: A Comprehensive Comparison
Discover the key differences between the endocannabinoid system and neurotransmitters in this informative comparison.
What the endocannabinoid system does
The endocannabinoid system (ECS) is a cell signaling network. It regulates pain, mood, memory, appetite, sleep, body temperature, and immune response. Three parts make it work: endocannabinoids, receptors, and enzymes. The system runs in the brain, spinal cord, immune organs, gut, skin, and bone. Researchers cloned the main receptor, CB1, in 1990. The first endocannabinoid, anandamide, was identified in 1992.
how does the endocannabinoid system work
The three parts
Endocannabinoids
Two endocannabinoids do most of the work. Anandamide (AEA) is a partial agonist. 2-arachidonoylglycerol (2-AG) is a full agonist. Cells make both on demand from fat molecules. The body stores neither in vesicles. Anandamide levels rise after exercise, which some studies link to runner's high. 2-AG sits at higher concentrations in the brain than anandamide.
Receptors
CB1 receptors sit on nerve cells. The hippocampus, cerebellum, basal ganglia, and cortex hold the highest counts. CB2 receptors sit on immune cells, such as microglia, macrophages, and B cells. The spleen, thymus, and gut hold dense CB2 populations. THC binds both receptors. CB1 activation drives the psychoactive effects of cannabis.
endocannabinoid system receptors
Enzymes
Two enzymes clear the signals. FAAH breaks down anandamide. MAGL breaks down 2-AG. Both convert the molecules into fatty acids. This step ends receptor signaling. Enzyme activity controls how long each signal lasts.
endocannabinoid system for beginners
How it controls body functions
Known roles include:
- Pain: CB1 and CB2 reduce pain signaling in the spinal cord and peripheral nerves.
- Appetite: CB1 activation in the hypothalamus raises food intake.
- Memory: CB1 in the hippocampus helps clear old memories and form new ones.
- Stress: CB1 modulates the HPA axis and cortisol release.
- Immune response: CB2 changes cytokine release and inflammation.
- Sleep: endocannabinoid levels shift with the sleep-wake cycle.
THC, CBD, and the ECS
THC is a plant compound that binds CB1 and CB2. Its shape lets it activate both receptors. CBD does not bind either receptor with meaningful strength. CBD acts on other targets, such as TRPV1 and 5-HT1A. CBD also slows FAAH, which can raise anandamide levels. This difference explains why THC and CBD produce different effects.
What researchers still do not know
Scientists do not agree on a single baseline for endocannabinoid tone. Levels change by tissue, time of day, and health status. Clinical trials of FAAH inhibitors stopped after liver problems in phase 1. The ECS is a drug target, but no approved medicine hits it with high selectivity.